OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2022
(4)
2023
(3)
2024
(2)
2014
(2)
2021
(1)
2018
(1)
2013
(1)
2011
(1)
2010
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Not available
S-EPMC9249725
|
biostudies-literature
Cite
Effective Lipid Extraction from Fat Balls Using Liquefied Dimethyl Ether: Process Optimization with a Box-Behnken Design.
Not available
S-EPMC11325427
|
biostudies-literature
Cite
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
Not available
S-EPMC2939784
|
biostudies-literature
Cite
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.
Not available
S-EPMC4161910
|
biostudies-literature
Cite
Plasma free amino acid profiling of five types of cancer patients and its application for early detection.
Not available
S-EPMC3168486
|
biostudies-literature
Cite
Clinical impact of cardiac magnetic resonance in patients with suspected coronary artery disease associated with chronic kidney disease (AQUAMARINE-CKD study): study protocol for a randomized controlled trial.
Not available
S-EPMC9590223
|
biostudies-literature
Cite
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811).
Not available
S-EPMC2658533
|
biostudies-literature
Cite
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692
|
biostudies-literature
Cite
The 3rd DBCLS BioHackathon: improving life science data integration with Semantic Web technologies.
Not available
S-EPMC3598643
|
biostudies-literature
Cite
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC9639796
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets